Another Targeted Therapy for ERBB2-Positive Breast Cancer

被引：3
|
作者：
Voelker, Rebecca
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2020年 / 323卷 / 05期
关键词：
D O I：
10.1001/jama.2020.0222
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：408 / 408
页数：1
相关论文
共 50 条
  • [1] Development of targeted therapies in ErbB2-positive breast cancer
    Jackisch, Christian
    Rueschoff, Josef
    Ullrich, Axel
    [J]. BREAST CARE, 2008, 3 : 3 - 6
  • [2] Therapy of the advanced ErbB2-positive breast cancer with Lapatinib
    Bock, Stefanie
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 (07) : 758 - 758
  • [3] The Prevalence and Assessment of ErbB2-Positive Breast Cancer in Asia
    Tan, Yew Oo
    Han, Sehwan
    Lu, Yen-Shen
    Yip, Cheng-Har
    Sunpaweravong, Patrapim
    Jeong, Joon
    Caguioa, Priscilla B.
    Aggarwal, Shyam
    Yeoh, Ee Min
    Moon, Hanlim
    [J]. CANCER, 2010, 116 (23) : 5348 - 5357
  • [4] PPARγ maintains ERBB2-positive breast cancer stem cells
    Wang, Xianhui
    Sun, Yan
    Wong, Jason
    Conklin, Douglas
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [5] PPARγ maintains ERBB2-positive breast cancer stem cells
    Wang, X.
    Sun, Y.
    Wong, J.
    Conklin, D. S.
    [J]. ONCOGENE, 2013, 32 (49) : 5512 - 5521
  • [6] Practice Patterns and Outcomes of Novel Targeted Agents for the Treatment of ERBB2-Positive Metastatic Breast Cancer
    Ethier, Josee-Lyne
    Desautels, Danielle
    Robinson, Andrew
    Amir, Eitan
    Kong, Weidong
    Booth, Christopher M.
    [J]. JAMA ONCOLOGY, 2021, 7 (09)
  • [7] Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
    Wolfson, Eya
    Solomon, Shira
    Schmukler, Eran
    Goldshmit, Yona
    Pinkas-Kramarski, Ronit
    [J]. CELL DEATH & DISEASE, 2018, 9
  • [8] Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer
    Eya Wolfson
    Shira Solomon
    Eran Schmukler
    Yona Goldshmit
    Ronit Pinkas-Kramarski
    [J]. Cell Death & Disease, 9
  • [9] Systemic Therapy for Women with ErbB2-Positive Breast Cancer: New Options, New Challenges
    Jackisch, Christian
    Untch, Michael
    [J]. BREAST CARE, 2010, 5 : 1 - 2
  • [10] PPARγ maintains ERBB2-positive breast cancer stem cells
    X Wang
    Y Sun
    J Wong
    D S Conklin
    [J]. Oncogene, 2013, 32 : 5512 - 5521
12345